If your doctor isn't closely following this and keeping you up-to-date on results you need a new doctor.
Your chances of getting dementia.
1. A documented 33% dementia chance post-stroke from an Australian study? May 2012.
2. Then this study came out and seems to have a range from 17-66%. December 2013.
3. A 20% chance in this research. July 2013.
4. Dementia Risk Doubled in Patients Following Stroke September 2018
5. Parkinson’s Disease May Have Link to Stroke March 2017
An Alzheimer's vaccine could be ready for human trials within 2 years
A vaccine that both prevents and treats
Alzheimer's disease could be ready for human trials in as little as 18
months, according to scientists.
Researchers have developed a treatment that successfully prevents and removes the build up of amyloid and tau proteins in the brains of genetically-engineered mice. These proteins clump together in the brain, forming plaques that cause neurodegeneration, scientists believe.
The vaccine, developed by Nikolai Petrovsky, an endocrinologist at Flinders University in Australia, combines two previous treatments respectively designed to reduce amyloid and tau protein clumps.
The study found the vaccine both prevents the buildup of proteins and removes those that already exist. The University of California, Irvine and the Institute for Molecular Medicine led the study.
"We were able to prevent the memory loss in the mice and obviously the next step is to take this into human clinical trials," Petrovsky told ABC News Australia. "It's an exciting time to be starting the new decade – hopefully this is the breakthrough of the next decade if we can get it to work in the human trials."
Those trials could begin in the next 18 to 24 months, he said.
An estimated 14 million adults are expected to have dementia by 2060, according to the U.S. Centers for Disease Control and Prevention. As of 2014, there were about 5 million adults with dementia.
Researchers have developed a treatment that successfully prevents and removes the build up of amyloid and tau proteins in the brains of genetically-engineered mice. These proteins clump together in the brain, forming plaques that cause neurodegeneration, scientists believe.
- RELATED STORIES
- Extra virgin olive oil could help prevent dementia, Temple researchers find
- Adjusting memory test may better detect Alzheimer's disease among women, study says
- Chair yoga could improve quality of life for dementia patients
- 'Striking' discovery gives hope for future drugs to prevent Alzheimer's
The vaccine, developed by Nikolai Petrovsky, an endocrinologist at Flinders University in Australia, combines two previous treatments respectively designed to reduce amyloid and tau protein clumps.
The study found the vaccine both prevents the buildup of proteins and removes those that already exist. The University of California, Irvine and the Institute for Molecular Medicine led the study.
"We were able to prevent the memory loss in the mice and obviously the next step is to take this into human clinical trials," Petrovsky told ABC News Australia. "It's an exciting time to be starting the new decade – hopefully this is the breakthrough of the next decade if we can get it to work in the human trials."
Those trials could begin in the next 18 to 24 months, he said.
An estimated 14 million adults are expected to have dementia by 2060, according to the U.S. Centers for Disease Control and Prevention. As of 2014, there were about 5 million adults with dementia.
No comments:
Post a Comment